Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

Detection of a Streptomycin/Spectinomycin Adenylyltransferase Gene (aadA) in Enterococcus faecalis

Nancye C. Clark, Ørjan Olsvik, Jana M. Swenson, Carol A. Spiegel, Fred C. Tenover
Nancye C. Clark
Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ørjan Olsvik
Department of Medical Microbiology, School of Medicine, University of Tromsø, Tromsø, Norway; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jana M. Swenson
Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carol A. Spiegel
Department of Pathology and Laboratory Medicine, University of Wisconsin Hospital and Clinics, Madison, Wisconsin 53792
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fred C. Tenover
Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.43.1.157
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Genes encoding streptomycin/spectinomycin adenylyltransferases [ANT(3")(9)] have been reported to exist in gram-negative organisms and Staphylococcus aureus. During a study of high-level aminoglycoside resistance in enterococci, we encountered an isolate ofEnterococcus faecalis that was streptomycin resistant but did not appear to contain the 6′-adenylyltransferase gene (aadE) when examined by PCR with specific primers. Phosphocellulose paper binding assays indicated the presence of an ANT(3")(9) enzyme. Streptomycin and spectinomycin MICs of 4,000 and 8,000 μg/ml, respectively, were observed for the isolate. PCR primers corresponding to a highly conserved region of the aadA gene were used to amplify a specific 284-bp product. The product hybridized with a digoxigenin-labeled PCR product from E. coliC600(pHP45Ω) known to contain the aadA gene. TheaadA gene was transferred via filter matings from theE. faecalis donor to E. faecalisJH2-2. PCR primers designed for analysis of integrons were used to amplify a 1-kb product containing the aadA gene, which was cloned into the vector pCRII and transformed into Escherichia coli DH5-α competent cells. d-Rhodamine dye terminator cycle sequencing was used to determine the gene sequence, which was compared to previously reported sequences of aadAgenes. We found the aadA gene in E. faecalis to be identical to the aadA genes reported by Sundström et al. for E. coli plasmid R6-5 (L. Sundström, P. Rådström, G. Swedberg, and O. Sköld, Mol. Gen. Genet. 213:191–201, 1988), by Fling et al. for theaadA within transposon Tn7 (M. E. Fling, J. Kopf, and C. Richards, Nucleic Acids Res. 13:7095–7106, 1985), and by Hollingshead and Vapnek for E. coliR538-1 (S. Hollingshead and D. Vapnek, Plasmid 13:17–30, 1985). Previous reports of the presence of the aadA gene in enterococci appear to be erroneous and probably describe anaadE gene, since the isolates were reported to be susceptible to spectinomycin.

Streptomycin continues to be an important drug for synergistic therapy of serious enterococcal infections (10). Resistance to streptomycin can be mediated by ribosomal mutation or by enzymatic modification of the drug. Ribosomal resistance is usually associated with streptomycin MICs of >32,000 μg/ml (11), while enzyme-mediated resistance produces lower MICs. The aadA gene, which encodes resistance to streptomycin and spectinomycin via an adenylyltransferase [ANT(3")(9)] enzyme, has been reported to exist in gram-negative organisms (3, 6, 15, 16, 33) and Staphylococcus aureus (7). Although there have been reports of streptomycin adenylyltransferases in enterococci (6, 8, 18), none of the isolates reported were resistant to spectinomycin, suggesting a mechanism other than one involving the ANT(3")(9) enzyme. In large surveys of clinical isolates, neither Leclercq et al. nor Ounissi et al. reported the identification of an ANT(3")(9) in enterococci (20, 25). However, a clinical isolate ofEnterococcus faecalis exhibiting high-level resistance to streptomycin and spectinomycin (MICs of ≥2,000 μg/ml) was recently recognized in a multilaboratory study of screening methods for detection of high-level aminoglycoside resistance in enterococci (32). The isolate did not exhibit ribosomal resistance since the streptomycin MIC was <32,000 μg/ml, failed to produce anaadE (also referred to as the ant6′ gene)-specific product when tested by PCR, and did not hybridize with an aadE-specific gene probe, suggesting an alternate mechanism of streptomycin resistance.

The goal of this study was to characterize the mechanism of streptomycin resistance in this isolate.

MATERIALS AND METHODS

Bacterial isolates.The E. faecalis strain used in this study (W4770) was originally isolated from a patient at the University of Wisconsin Hospital, Madison, Wis., and was sent to the Centers for Disease Control and Prevention, where it was confirmed to be E. faecalis by the performance of biochemical tests described by Facklam and Collins (12). Strains were grown on Trypticase soy agar with 5% sheep blood (Becton Dickinson Microbiology Systems, Cockeysville, Md.) at 35°C. The control strains used throughout the study were as follows: rifampin-resistant (Rifr) and fusidic acid-resistant (Fusr)E. faecalis JH2-2 (plasmid free) (17); streptomycin-resistant (Strr), spectinomycin-resistant (Spr), and ampicillin-resistant Escherichia coliC600(pHP45Ω) (aadA) (26); E. faecalis ATCC 49532 [aac(6′)-aph(2")] (32), ATCC 49533 (aadE) (32), and Strr (ribosomal) E1-R (11); SprS. aureus 8325-4 [ant(9′)] (24);E. coli C600(pFCT3103) [ant(2")] (34); and Bacillus subtilis pUBH2[ant(4′)] (9).

Antimicrobial susceptibility testing.All isolates were tested by the broth microdilution method as described by the National Committee for Clinical Laboratory Standards, using cation-adjusted Mueller-Hinton broth (Difco Laboratories, Detroit, Mich.) (23). The antimicrobials tested were ampicillin, chloramphenicol, ciprofloxacin, gentamicin, imipenem, penicillin, quinupristin/dalfopristin, rifampin, spectinomycin, streptomycin, teicoplanin, tetracycline, and vancomycin.

AME assays.Lysates of bacterial strains were screened for the presence of aminoglycoside-modifying enzymes (AMEs) by the phosphocellulose binding assay as described by Cooksey et al. (4). The only modification of their procedure was that the wash buffer (10 mM Tris, 1 mM EDTA; pH 7.4) and the suspension buffer (10 mM Tris, 10 mM MgCl2, 10 mM dithiothreitol; pH 6.8) used for the enterococci were those described by Chen and Williams (2).

PCR amplification of resistance genes.The oligonucleotide primers chosen for amplification of the 6′-streptomycin adenylyltransferase (aadE) and the 3"-adenylyltransferase (aadA) genes (Table 1) were selected from published sequences (13, 16) with the assistance of OLIGO software, version 4.0 (National Biosciences, Hamel, Maine). The PCR mixtures and conditions for amplification of theaac(6′)-aph(2") and the aadE genes have been described previously (32).

View this table:
  • View inline
  • View popup
Table 1.

PCR amplification of aminoglycoside resistance genes

For amplification of the aadA gene, four or five bacterial colonies from an overnight plate were suspended in 100 μl of a chilled reaction mixture containing 10 mM Tris–2.0 mM MgCl2–50 mM KCl (pH 8.3), 0.2 mM deoxynucleotide triphosphates (dATP, dCTP, dTTP, and dGTP), 0.5 μM each primer, and 2.5 U of Taq DNA polymerase (Boehringer Mannheim Biochemicals, Indianapolis, Ind.). A model 9600 DNA thermocycler (Perkin-Elmer Cetus, Emeryville, Calif.) was programmed as follows: an initial denaturation for 10 min at 95°C; 30 cycles consisting of a 30-s denaturation step at 94°C, a 30-s annealing at 60°C, and a 30-s extension step at 72°C; a 10-min extension step at 72°C; and incubation at 4°C until the analysis was performed.

Resistance gene probes.The probe used for detection of theaadE gene was that described by Swenson et al. (32) and consisted of a digoxigenin-labeled 597-bp PCR product from E. faecalis JH2-2(pJH-1) (17). For detection of the aadA gene, a 284-bp PCR product fromE. coli plasmid pHP45Ω (26) was labeled with digoxigenin by using a Genius kit (Boehringer Mannheim), and hybridization was performed under stringent conditions at 68°C according to the manufacturer’s recommendations (1).

Transfer of resistance genes.Filter matings were performed by using E. faecalis W4770 as the donor andE. faecalis JH2-2 (17) as the recipient, as previously described (35). Overnight Trypticase soy broth (TSB) cultures of Strr, SprE. faecalis W4770 (donor) and Rifr, FusrE. faecalis JH2-2 (recipient) were mixed in a 20:1 ratio and filtered through a 0.22-μm-pore-size Nalgene filter (Nalgene Nunc International, Rochester, N.Y.). The membrane was placed on a brain heart infusion agar (BBL) plate and incubated for 24 h at 37°C. The growth was resuspended in 5 ml of TSB, and transconjugants were selected on brain heart infusion agar containing 50 μg of rifampin, 20 μg of fusidic acid, 50 μg of streptomycin, and 50 μg of spectinomycin/ml.

The transconjugants were examined for the presence of the resistance gene by PCR with specific aadA gene primers. Expression of the gene was demonstrated by determination of streptomycin, spectinomycin, and tetracycline MICs by the broth microdilution method (23).

Sequencing of the resistance gene.Using the oligonucleotide primers designed by Lévesque et al. for PCR analysis of integrons (21, 22), we generated a PCR product of approximately 1 kb, using cesium chloride-purified plasmid DNA as the template (27). The 100-μl reaction mixture included 1× PCR buffer II; 2 mM MgCl2; 0.2 mM (each) dATP, dCTP, dGTP, and dTTP; 10 μl of each primer (2.5 pmol/ml stock); and 2.5 U of AmpliTaq Gold DNA polymerase (Perkin-Elmer Applied Biosystems, Foster City, Calif.). The thermocycler was programmed as follows: an initial denaturation for 12 min at 95°C; 30 cycles consisting of a 30-s denaturation step at 94°C, a 30-s annealing at 55°C, and a 30-s extension step at 72°C; a 10-min extension step at 72°C; and incubation at 4°C until the analysis was performed. The products were purified on QIAquick PCR spin columns (Qiagen, Inc., Chatsworth, Calif.), and the DNA was eluted from the columns with 10 mM Tris, pH 9.0.

The integron PCR DNA was ligated into the pCRII vector (TA Cloning Kit; Invitrogen, Carlsbad, Calif.) and transformed into E. coli Library Efficiency DH5-α competent cells (Gibco/BRL Life Technologies, Inc., Gaithersburg, Md.). The DH5-α competent cells are Strs, allowing streptomycin to be used for selection of the transformants; the competent cells normally supplied with the TA Cloning Kit are resistant. The transformants were inoculated into 5 ml of TSB containing 100 μg of ampicillin/ml and incubated at 37°C with shaking for 6 h. The plasmid DNA was purified by using a Qiagen plasmid minikit and then digested with EcoRI (Gibco/BRL Life Technologies, Inc.) to check for insertions into the vector DNA. The purified transformant plasmid DNA from multiple clones with an insert of approximately 1 kb was used as the template for the sequencing reaction.

The samples for sequencing were prepared in a 10-μl volume by using an ABI PRISM dRhodamine terminator cycle sequencing kit with AmpliTaq DNA polymerase, FS (Perkin-Elmer Applied Biosystems), and 3.2 pmol of stocks of both the forward and reverse integron and aadAgene PCR primers. The thermocycler was preheated to 96°C, the program was aborted, and the samples were added; then the thermocycler was programmed for 25 cycles of a 10-s denaturing step at 96°C, a 5-s annealing step at 50°C, a 4-min extension step at 60°C, and a holding step at 4°C. The dye terminators were removed from the samples by passing the samples through CentriSep columns (Princeton Separations, Adelphia, N.J.), and the samples were dried in a SpeedVac vacuum centrifuge (Savant Instruments, Inc., Holbrook, N.J.) without heat. The samples were electrophoresed in a 5% Gene Page-Plus acrylamide gel with 6 M urea in 1× Tris-borate-EDTA buffer (Ultrapure grade TBE; AMRESCO, Solon, Ohio) on an ABI PRISM model 377 DNA sequencer (Perkin-Elmer Applied Biosystems).

Nucleotide sequence accession number.The E. faecalis aadA gene sequence has been deposited in the GenBank database under accession no. AF052459.

RESULTS

Antimicrobial susceptibility testing. E. faecalisW4770 was resistant to streptomycin and spectinomycin (MICs, 4,000 and 8,000 μg/ml, respectively), as well as to tetracycline (MIC, >16 μg/ml). The isolate was susceptible to ampicillin, chloramphenicol, ciprofloxacin, gentamicin, imipenem, penicillin, quinupristin/dalfopristin, rifampin, teicoplanin, and vancomycin.

AME assays.The isolate and controls were lysed and tested for AME activity. Only the assays for adenylyltransferase and phosphotransferase were performed, since streptomycin and spectinomycin are modified only by those classes of enzymes. W4770 gave a modification pattern consistent with the production of the ANT(3")(9) enzyme by modifying streptomycin and spectinomycin but not amikacin, butirosin, gentamicin, kanamycin, neomycin, paromomycin, or tobramycin, as did E. coli C600(pPHP45Ω), which is known to produce ANT(3")(9) enzyme. No phosphotransferase activity was demonstrated except in the control isolate E. faecalisATCC 49532.

PCR amplification of resistance genes and specific gene probing.The specific 284-bp aadA gene product was amplified from both plasmid and total DNA obtained from W4770, and the specificity of the PCR product was confirmed with the digoxigenin-labeled product from E. coliC600(pHP45Ω). Control strains containing the aadAgene were positive by PCR for the 284-bp product; no product was demonstrated with strains containing other AME genes [aadE, ant(2"), ant(4"),ant(9′), aac(6′), or aph(2")]. No gene amplification was seen in the isolate with the aadE- and aph(2")-aac(6′)-specific primers.

Transfer of resistance genes.A resistance plasmid (pNCC801) of approximately 80 kb was transferred by conjugation from strain W4770 to E. faecalis JH2-2 at a frequency of ∼3 × 10−10. The MICs of streptomycin and spectinomycin for the transconjugants were 2,000 and 4,000 μg/ml, respectively; the transconjugants were also resistant to tetracycline. The 284-bp aadA gene product was amplified from the transconjugants. The BamHI,EcoRI, and HindIII restriction profiles for pNCC801 and the plasmids present in the JH2-2 transconjugants were identical (data not shown).

Cloning and sequencing of the resistance gene.The 1,009-bp PCR product amplified by integron primers 1 and 2 fromE. faecalis W4770 was cloned into pCRII. The sequence from the integron containing the aadA gene is presented in Fig. 1. Our 1,009-bp sequence is identical to that reported by Sundström et al. for E. coli plasmid R6-5 (GenBank accession no. X12870) from bases 1192 to 2201 (30), as well as to bases 5298 to 6306 of the recently assembled sequence of transposon Tn21 (GenBank accession no. AF071413). The 791-bp enterococcal aadAstructural gene sequence (bases 107 to 898) was identical to that in plasmid R538-1 in E. coli K-12 (bases 399 to 1190 of GenBank accession no. M10241) and was 99.4% homologous to the sequence reported by Fling et al. (15) for Tn7 (GenBank accession no. X03043, bases 82 to 873), except for the substitutions of an A for a G at position 790 and a C for a T at position 856, neither of which resulted in an amino acid change. However, an AGA insertion in the enterococcal sequence (bases 814 to 816) did result in an additional glutamic acid (E) residue.

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Nucleotide sequence and predicted amino acid sequence of the plasmid-mediated aadA-1 gene of E. faecalis W4770. The 1,009-bp PCR product was amplified with oligonucleotide primers specific for the integron cassette described by Lévesque et al. (21, 22). The gene insertion sites (GTTA) for the integron, at the 3′ end of each of the two shaded areas which highlight the hs2 (14 bp) and hs1 (55 bp) hot spots; the initiation and stop codons are in boldface type; and the 59-bp element is underlined (28).

When the entire 1,009-bp enterococcal sequence was compared with the sequence of R538-1 determined by Hollingshead and Vapnek (16), there was 99.5% homology as a result of a deletion of a C residue after base 933, the addition of a CGGC sequence (bases 938 to 941), and deletion of an A after base 954. Our sequence of the 1,009-bp amplification product from control organism E. coli C600(pHP45Ω) containing the aadA gene from R100.1 (26) is identical to that from W4770.

The 59-bp element sequences containing the hs1 hot spot (28), located downstream of the aadA gene, were identical in W4770, Tn7, and pHP45Ω (Fig. 1). However, the Tn7 integron sequence upstream of the 5′ insertion site (GTTA) also contains an hs1 hot spot (28). Thus, it differs from the W4770, pHP45Ω, and R538-1 sequences, which are identical to each other and contain hs2 hot spots (28) (Fig. 1).

DISCUSSION

In 1981, Kono et al. reported the presence of ANT(3") activity in an isolate of E. faecalis (18). Similar results were reported by Courvalin et al. in 1978 for the E. faecalis transconjugants of three clinical isolates (8), including strains JH2-14 (derived fromEnterococcus faecium JH-7), JH2-15 (derived fromE. faecalis JH-1 containing pJH-1), and JH2-12 (derived from E. faecalis JH-6). All of the isolates had high streptomycin MICs of >2,000 μg/ml but were susceptible to spectinomycin (MIC, 64 μg/ml). Courvalin et al. (8) attributed the adenylylation of streptomycin to the ANT(6′) (aadE) activity in their strains, since they were susceptible to spectinomycin as is typical for S. aureusstrains carrying this determinant (31).

In 1992, Leclercq et al. noted that the AME ANT(3")(9) was produced in staphylococci but not in enterococci (20). Our report of the ANT(3")(9) enzyme in enterococci was not surprising since many other enterococcal genes, e.g., β-lactamase, ant(4′), andaac(6′)-(aph(2"), were originally recognized in staphylococci (5, 6, 20, 25, 36). The ANT(9) enzyme, which mediates resistance to spectinomycin only, also appears to have its origins in staphylococci (19, 20).

Integrons are found either as part of transposons or independently on broad-host-range plasmids, but to our knowledge their presence has only been reported in gram-negative organisms (21, 29). Integrons typically have two conserved segments, 5′ and 3′, separated by a variable region which includes integrated antimicrobial resistance genes or cassettes. The 5′ conserved segment contains the integrase gene and, on the opposite strand, a common promoter region, P1-P2, which is directed toward the site of integration. Most genes inserted into integrons lack their own promoters and are expressed by the use of the common promoter region. The 3′ conserved segment contains the genes that determine resistance to quaternary ammonium compounds and sulfonamide, in addition to an open reading frame (21, 29). At the 3′ end of each resistance gene cassette is a short inverted-repeat element called the 59-bp element. The 59-bp element, which can vary to a certain degree in sequence and length, is important in the site-specific recombination event that results in the insertion of individual genes.

The integron sequence containing the aadA gene from E. faecalis W4770 was located on a plasmid of approximately 80 kb (pNCC801) which was transferable at a low frequency to E. faecalis JH2-2. The DNA sequences of the 1,009-bp amplification product from W4770 and the E. coli plasmids R6-5 (30) and pHP45Ω (26) were identical. The differences between our sequences and those of Hollingshead and Vapnek (16) for R538-1 were probably due to technical factors relating to earlier sequencing methods, as previously noted by Fling et al. (15). Our aadA sequence was preceded by an hs2 hot spot and followed by an hs1 hot spot, which included the characteristic 59-bp element described by Schmidt et al. (28). Our results suggested that the aadA gene was the only resistance gene inserted within the integron, since the PCR product was not of sufficient size to include other cassettes. It is unclear whether this integron is part of a larger transposon, but based on the sequence data, the integron does appear to have originated from an enteric organism.

ACKNOWLEDGMENTS

We thank Kamile Rasheed and Linda Weigel for technical assistance and helpful discussions and members of the Biotechnology Core Facility Branch at the Centers for Disease Control and Prevention for oligonucleotide primer preparation and supportive expertise.

FOOTNOTES

    • Received 16 April 1998.
    • Returned for modification 15 July 1998.
    • Accepted 27 October 1998.
  • Copyright © 1999 American Society for Microbiology

REFERENCES

  1. 1.↵
    Boehringer Mannheim Biochemicals The Genius system user’s guide for filter hybridization. 1992 Boehringer Mannheim Biochemicals Indianapolis, Ind
  2. 2.↵
    1. Chen H. Y.,
    2. Williams J. D.
    Transferable resistance and aminoglycoside-modifying enzymes in enterococci. J. Med. Microbiol. 20 1985 187 196
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Chinault A. C.,
    2. Blakesley V. A.,
    3. Roessler E.,
    4. Willis D. G.,
    5. Smith C. A.,
    6. Cook R. G.,
    7. Fenwick R. G. Jr.
    Characterization of transferable plasmids from Shigella flexneri 2a that confer resistance to trimethoprim, streptomycin, and sulfonamides. Plasmid 15 1986 119 131
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Cooksey R. C.,
    2. Metchock B. G.,
    3. Thornsberry C.
    Microplate phosphocellulose binding assay for aminoglycoside-modifying enzymes. Antimicrob. Agents Chemother. 30 1986 883 887
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Courvalin P.,
    2. Carlier C.,
    3. Collatz E.
    Plasmid-mediated resistance to aminocyclitol antibiotics in group D streptococci. J. Bacteriol. 143 1980 541 551
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Courvalin P.,
    2. Carlier C.,
    3. Collatz E.
    Evolutionary relationships between plasmid-mediated aminoglycoside-modifying enzymes from gram-positive and gram-negative bacteria New trends in antibiotics: research and therapy. Grassi G. G., Sabath L. D. 1981 95 109 Elsevier/North-Holland Biomedical Press New York, N.Y
  7. 7.↵
    1. Courvalin P.,
    2. Fiandt M.
    Aminoglycoside-modifying enzymes of Staphylococcus aureus; expression in Escherichia coli. Gene 9 1980 247 269
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Courvalin P.,
    2. Shaw W. V.,
    3. Jacob A. E.
    Plasmid-mediated mechanisms of resistance to aminoglycoside-aminocyclitol antibiotics and to chloramphenicol in group D streptococci. Antimicrob. Agents Chemother. 13 1978 716 725
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Dickgiesser N.,
    2. Kreiswirth B. N.
    Determination of aminoglycoside resistance in Staphylococcus aureus by DNA hybridization. Antimicrob. Agents Chemother. 29 1986 930 932
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Eliopoulos G. M.,
    2. Eliopoulos C. T.
    Therapy of enterococcal infections. Eur. J. Clin. Microbiol. Infect. Dis. 9 1990 118 126
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Eliopoulos G. M.,
    2. Farber B. F.,
    3. Murray B. E.,
    4. Wennersten C.,
    5. Moellering R. C. Jr.
    Ribosomal resistance of clinical enterococcal isolates to streptomycin. Antimicrob. Agents Chemother. 25 1984 398 399
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Facklam R. R.,
    2. Collins M. D.
    Identification of Enterococcus species isolated from human infections by a conventional test scheme. J. Clin. Microbiol. 27 1989 731 734
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Ferretti J. J.,
    2. Curtiss R. III
    Streptococcal genetics. 1987 American Society for Microbiology Washington, D.C
  14. 14.
    1. Ferretti J. J.,
    2. Gilmore K. S.,
    3. Courvalin P.
    Nucleotide sequence analysis of the gene specifying the bifunctional 6′-aminoglycoside acetyltransferase 2"-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two activities. J. Bacteriol. 167 1986 631 638
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Fling M. E.,
    2. Kopf J.,
    3. Richards C.
    Nucleotide sequence of the transposon Tn7 gene encoding an aminoglycoside-modifying enzyme, 3"(9)-O-nucleotidyltransferase. Nucleic Acids Res. 13 1985 7095 7106
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Hollingshead S.,
    2. Vapnek D.
    Nucleotide sequence analysis of a gene encoding a streptomycin/spectinomycin adenyltransferase. Plasmid 13 1985 17 30
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Jacob A. E.,
    2. Hobbs S. J.
    Conjugal transfer of plasmid-borne multiple antibiotic resistance in Streptococcus faecalis var. zymogenes. J. Bacteriol. 117 1974 360 372
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Kono M.,
    2. Hamashima H.,
    3. O’Hara K.
    Modification of aminoglycoside antibiotics by clinical isolates of Streptococcus faecalis. J. Antibiot. 34 1981 224 230
    OpenUrlPubMed
  19. 19.↵
    1. LeBlanc D. J.,
    2. Lee L. N.,
    3. Inamine J. M.
    Cloning and nucleotide base sequence analysis of a spectinomycin adenyltransferase AAD(9) determinant from Enterococcus faecalis. Antimicrob. Agents Chemother. 35 1991 1804 1810
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Leclercq R.,
    2. Dutka-Malen S.,
    3. Brisson-Nöel A.,
    4. Molinas C.,
    5. Derlot E.,
    6. Arthur M.,
    7. Duval J.,
    8. Courvalin P.
    Resistance of enterococci to aminoglycosides and glycopeptides. Clin. Infect. Dis. 15 1992 495 501
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Lévesque C.,
    2. Piché L.,
    3. Larose C.,
    4. Roy P. H.
    PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39 1995 185 191
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Lévesque C.,
    2. Roy P. H.
    PCR analysis of integrons Diagnostic molecular microbiology: principles and applications. Persing D. H., Smith T. F., Tenover F. C., White T. J. 1993 590 594 American Society for Microbiology Washington, D.C
  23. 23.↵
    National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 4th ed. Approved standard M7-A4. 1997 National Committee for Clinical Laboratory Standards Wayne, Pa
  24. 24.↵
    1. Novick R. P.,
    2. Murphy E.,
    3. Gryczan T. J.,
    4. Baron E.,
    5. Edelman I.
    Penicillinase plasmids of Staphylococcus aureus: restriction-deletion maps. Plasmid 2 1979 109 129
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Ounissi H.,
    2. Derlot E.,
    3. Carlier C.,
    4. Courvalin P.
    Gene homogeneity for aminoglycoside-modifying enzymes in gram-positive cocci. Antimicrob. Agents Chemother. 34 1990 2164 2168
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Prentki P.,
    2. Krisch H. M.
    In vitro insertional mutagenesis with a selectable DNA fragment. Gene 29 1984 303 313
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Sambrook J.,
    2. Fritsch E. F.,
    3. Maniatis T.
    Molecular cloning: a laboratory manual 2nd ed. 1989 Cold Spring Harbor Laboratory Cold Spring Harbor, N.Y
  28. 28.↵
    1. Schmidt F. R. J.,
    2. Nücken E. J.,
    3. Henschke R. B.
    Structure and function of hot spots providing signals for site-directed specific recombination and gene expression in Tn21 transposons. Mol. Microbiol. 3 1989 1545 1555
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Stokes H. W.,
    2. Hall R. M.
    A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: integrons. Mol. Microbiol. 3 1989 1669 1683
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Sundström L.,
    2. Rådström P.,
    3. Swedberg G.,
    4. Sköld O.
    Site-specific recombination promotes linkage between trimethoprim and sulfonamide resistance genes. Sequence characterization of dhfrV and sulI and a recombination active locus of Tn21. Mol. Gen. Genet. 213 1988 191 201
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Suzuki I.,
    2. Takahashi N.,
    3. Shirato S.,
    4. Kawabe H.,
    5. Mitsuhashi S.
    Adenylylation of streptomycin by Staphylococcus aureus: a new streptomycin adenylyltransferase Microbial drug resistance. Mitsuhashi S., Hajimoto H. 1975 463 473 University Park Press Baltimore, Md
  32. 32.↵
    1. Swenson J. M.,
    2. Ferraro M. J.,
    3. Sahm D. F.,
    4. Clark N. C.,
    5. Culver D. H.,
    6. Tenover F. C.,
    7. The National Committee for Clinical Laboratory Standards Study Group on Enterococci
    Multilaboratory evaluation of screening methods for detection of high-level aminoglycoside resistance in enterococci. J. Clin. Microbiol. 33 1995 3008 3018
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Tait R. C.,
    2. Rempel H.,
    3. Rodriguez R. L.,
    4. Kado C. I.
    The aminoglycoside-resistance operon of the plasmid pSa: nucleotide sequence of the streptomycin-spectinomycin resistance gene. Gene 36 1985 97 104
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    1. Tenover F. C.,
    2. Gootz T. D.,
    3. Gordon K. P.,
    4. Tompkins L. S.,
    5. Young S. A.,
    6. Plorde J. J.
    Development of a DNA probe for the structural gene of the 2"-O-adenyltransferase aminoglycoside-modifying enzyme. J. Infect. Dis. 150 1984 678 687
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Trieu-Cuot P.,
    2. Carlier C.,
    3. Courvalin P.
    Conjugative plasmid transfer from Enterococcus faecalis to Escherichia coli. J. Bacteriol. 170 1988 4388 4391
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Zscheck K. K.,
    2. Hull R.,
    3. Murray B. E.
    Restriction mapping and hybridization studies of a β-lactamase-encoding fragment from Streptococcus (Enterococcus) faecalis. Antimicrob. Agents Chemother. 32 1988 768 769
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Detection of a Streptomycin/Spectinomycin Adenylyltransferase Gene (aadA) in Enterococcus faecalis
Nancye C. Clark, Ørjan Olsvik, Jana M. Swenson, Carol A. Spiegel, Fred C. Tenover
Antimicrobial Agents and Chemotherapy Jan 1999, 43 (1) 157-160; DOI: 10.1128/AAC.43.1.157

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Detection of a Streptomycin/Spectinomycin Adenylyltransferase Gene (aadA) in Enterococcus faecalis
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Detection of a Streptomycin/Spectinomycin Adenylyltransferase Gene (aadA) in Enterococcus faecalis
Nancye C. Clark, Ørjan Olsvik, Jana M. Swenson, Carol A. Spiegel, Fred C. Tenover
Antimicrobial Agents and Chemotherapy Jan 1999, 43 (1) 157-160; DOI: 10.1128/AAC.43.1.157
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Enterococcus faecalis
Nucleotidyltransferases

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596